Literature DB >> 17462022

Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence.

Frédérique Moyrand1, Thierry Fontaine, Guilhem Janbon.   

Abstract

The polysaccharidic capsule is the main virulence factor of Cryptococcus neoformans. It primarily comprised of two polysaccharides: glucuronoxylomannan (GXM, 88% of the capsule mass) and galactoxylomannan (GalXM, 7% of the capsule mass). We constructed a large collection of mutant strains in which genes potentially involved in capsule biosynthesis were deleted. We used a new post-genomic approach to study the virulence of the strains. Primers specific for unique tags associated with the disruption cassette were used in a real-time PCR virulence assay to measure the fungal burden of each strain in different organs of mice in multi-infection experiments. With this very sensitive assay, we identified a putative UDP-glucose epimerase (Uge1p) and a putative UDP-galactose transporter (Ugt1p) essential for C. neoformans virulence. The uge1Delta and ugt1Delta strains are temperature sensitive and do not produce GalXM but synthesize a larger capsule. These mutant strains (GalXM negative, GXM positive) are not able to colonize the brain even at the first day of infection whereas GXM-negative strains (GalXM positive) can still colonize the brain, although less efficiently than the wild-type strain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462022     DOI: 10.1111/j.1365-2958.2007.05695.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  60 in total

1.  Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-12-21

2.  Multiple GAL pathway gene clusters evolved independently and by different mechanisms in fungi.

Authors:  Jason C Slot; Antonis Rokas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Characterization of a long-chain α-galactosidase from Papiliotrema flavescens.

Authors:  Barbora Stratilová; Jaroslav Klaudiny; Pavel Řehulka; Eva Stratilová; Csilla Mészárosová; Soňa Garajová; Barbora Pavlatovská; Helena Řehulková; Stanislav Kozmon; Sergej Šesták; Zuzana Firáková; Renáta Vadkertiová
Journal:  World J Microbiol Biotechnol       Date:  2018-01-04       Impact factor: 3.312

4.  PTS phosphorylation of Mga modulates regulon expression and virulence in the group A streptococcus.

Authors:  Elise R Hondorp; Sherry C Hou; Lara L Hause; Kanika Gera; Ching-En Lee; Kevin S McIver
Journal:  Mol Microbiol       Date:  2013-05-20       Impact factor: 3.501

5.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

6.  Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Authors:  Magdia De Jesus; André Moraes Nicola; Marcio L Rodrigues; Guilhem Janbon; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2008-10-24

7.  Three galactose inducible promoters for use in C. neoformans var. grubii.

Authors:  Jack A Ruff; Jennifer K Lodge; Lorina G Baker
Journal:  Fungal Genet Biol       Date:  2008-10-14       Impact factor: 3.495

8.  Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences.

Authors:  Susana Frases; Leonardo Nimrichter; Nathan B Viana; Antonio Nakouzi; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-12-21

9.  UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans.

Authors:  Frédérique Moyrand; Ingrid Lafontaine; Thierry Fontaine; Guilhem Janbon
Journal:  Eukaryot Cell       Date:  2008-09-26

10.  Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides.

Authors:  J Stacey Klutts; Tamara L Doering
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.